These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30924596)

  • 1. SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic-smoking interaction analysis.
    Zhang R; Lai L; Dong X; He J; You D; Chen C; Lin L; Zhu Y; Huang H; Shen S; Wei L; Chen X; Guo Y; Liu L; Su L; Shafer A; Moran S; Fleischer T; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
    Mol Oncol; 2019 May; 13(5):1235-1248. PubMed ID: 30924596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic-smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients.
    Ji X; Lin L; Shen S; Dong X; Chen C; Li Y; Zhu Y; Huang H; Chen J; Chen X; Wei L; He J; Duan W; Su L; Jiang Y; Fan J; Guan J; You D; Shafer A; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Zhang R; Chen F; Christiani DC
    Mol Oncol; 2020 Nov; 14(11):2759-2774. PubMed ID: 33448640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome-wide gene-age interaction analysis reveals reversed effects of
    Chen C; Wei Y; Wei L; Chen J; Chen X; Dong X; He J; Lin L; Zhu Y; Huang H; You D; Lai L; Shen S; Duan W; Su L; Shafer A; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Zhang R; Chen F; Christiani DC
    Aging (Albany NY); 2020 Jun; 12(11):10642-10662. PubMed ID: 32511103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenome-wide association study of smoking and DNA methylation in non-small cell lung neoplasms.
    Freeman JR; Chu S; Hsu T; Huang YT
    Oncotarget; 2016 Oct; 7(43):69579-69591. PubMed ID: 27602958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma.
    Qu Y; Zhang X; Qiao R; Di F; Song Y; Wang J; Ji L; Zhang J; Gu W; Fang Y; Han B; Yang R; Dai L; Ouyang S
    Respir Res; 2024 Jan; 25(1):59. PubMed ID: 38273401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X; Chen L; Zhang T
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
    Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
    Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations.
    Kuo IY; Jen J; Hsu LH; Hsu HS; Lai WW; Wang YC
    J Biomed Sci; 2016 Aug; 23(1):58. PubMed ID: 27484806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Landscape of epigenetically regulated lncRNAs and DNA methylation in smokers with lung adenocarcinoma.
    Jung J; Lee YJ; Kim CH; Ahn S
    PLoS One; 2021; 16(3):e0247928. PubMed ID: 33684161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AHRR (cg05575921) methylation extent of leukocyte DNA and lung cancer survival.
    Kemp Jacobsen K; Johansen JS; Mellemgaard A; Bojesen SE
    PLoS One; 2019; 14(2):e0211745. PubMed ID: 30730943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC.
    Ji X; Lin L; Fan J; Li Y; Wei Y; Shen S; Su L; Shafer A; Bjaanaes MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Zhang R; Chen F; Christiani DC
    Mol Oncol; 2022 Feb; 16(3):717-731. PubMed ID: 34932879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC.
    Zhang R; Lai L; He J; Chen C; You D; Duan W; Dong X; Zhu Y; Lin L; Shen S; Guo Y; Su L; Shafer A; Moran S; Fleischer T; Bjaanæs MM; Karlsson A; Planck M; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
    Epigenetics; 2019 Feb; 14(2):118-129. PubMed ID: 30665327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential
    Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K; Wu Y
    BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
    Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
    Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.
    Lee SM; Park JY; Kim DS
    Mol Cells; 2012 Aug; 34(2):171-6. PubMed ID: 22814847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel genome-wide DNA methylation profiling reveals distinct epigenetic landscape, prognostic model and cellular composition of early-stage lung adenocarcinoma.
    Gan J; Huang M; Wang W; Fu G; Hu M; Zhong H; Ye X; Cao Q
    J Transl Med; 2024 May; 22(1):428. PubMed ID: 38711158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of DNA methylation in bronchial washings.
    Um SW; Kim Y; Lee BB; Kim D; Lee KJ; Kim HK; Han J; Kim H; Shim YM; Kim DH
    Clin Epigenetics; 2018; 10():65. PubMed ID: 29796116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.